Journal of Cell Science, Vol 112, Issue 18 3081-3090, Copyright © 1999 by Company of Biologists

JOURNAL ARTICLES

Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/beta-catenin

S Hiscox and WG Jiang
Metastasis Research Group, University Department of Surgery, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, UK. jiangw@cf.ac.uk

Ezrin, radixin, moesin and merlin form a subfamily of conserved proteins in the band 4.1 superfamily. The function of these proteins is to link the plasma membrane to the actin cytoskeleton. Merlin is defective or absent in schwannomas and meningiomas and has been suggested to function as a tumour suppressor. In this study, we have examined the role of ezrin as a potential regulator of the adhesive and invasive behaviour of tumour cells. We have shown that following inhibition of ezrin expression in colo-rectal cancer cells using antisense oligonucleotides, these cells displayed a reduced cell-cell adhesiveness together with a gain in their motile and invasive behaviour. These cells also displayed increased spreading over matrix-coated surfaces. Immunofluorescence studies revealed that antisense-treated cells also displayed an increased staining of paxillin in areas representing focal adhesions. Furthermore, coprecipitation studies revealed an association of ezrin with E-cadherin and beta-catenin. Induction of the phosphorylation of ezrin by orthovanadate and hepatocyte growth factor/scatter factor resulted in changes similar to those seen with antisense treatment, together with a marked decrease in the association of ezrin with both beta-catenin and E-cadherin. It is concluded that ezrin regulates cell-cell and cell-matrix adhesion, by interacting with cell adhesion molecules E-cadherin and beta-catenin, and may thus play an important role in the control of adhesion and invasiveness of cancer cells.

This article has been cited by other articles:

				Y. Huang and J. K. Burkhardt T-cell-receptor-dependent actin regulatory mechanisms J. Cell Sci., March 1, 2007; 120(5): 723 - 730. [Abstract] [Full Text] [PDF]

				H. Zeng, L. Xu, D. Xiao, H. Zhang, X. Wu, R. Zheng, Q. Li, Y. Niu, Z. Shen, and E. Li Altered Expression of Ezrin in Esophageal Squamous Cell Carcinoma J. Histochem. Cytochem., August 1, 2006; 54(8): 889 - 896. [Abstract] [Full Text] [PDF]

				G. Casey, P. J. Neville, X. Liu, S. J. Plummer, M. S. Cicek, L. M. Krumroy, A. P. Curran, M. R. McGreevy, W. J. Catalona, E. A. Klein, et al. Podocalyxin variants and risk of prostate cancer and tumor aggressiveness Hum. Mol. Genet., March 1, 2006; 15(5): 735 - 741. [Abstract] [Full Text] [PDF]

				Y. Yu, E. Davicioni, T. J. Triche, and G. Merlino The Homeoprotein Six1 Transcriptionally Activates Multiple Protumorigenic Genes but Requires Ezrin to Promote Metastasis Cancer Res., February 15, 2006; 66(4): 1982 - 1989. [Abstract] [Full Text] [PDF]

				X. Wan, A. Mendoza, C. Khanna, and L. J. Helman Rapamycin Inhibits Ezrin-Mediated Metastatic Behavior in a Murine Model of Osteosarcoma Cancer Res., March 15, 2005; 65(6): 2406 - 2411. [Abstract] [Full Text] [PDF]

				J. Srivastava, B. E. Elliott, D. Louvard, and M. Arpin Src-dependent Ezrin Phosphorylation in Adhesion-mediated Signaling Mol. Biol. Cell, March 1, 2005; 16(3): 1481 - 1490. [Abstract] [Full Text] [PDF]

				J. Ma, J. Zhou, S. Fan, L. Wang, X. Li, Q. Yan, M. Zhou, H. Liu, Q. Zhang, H. Zhou, et al. Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion modulation in nasopharyngeal carcinoma cells Carcinogenesis, February 1, 2005; 26(2): 281 - 291. [Abstract] [Full Text] [PDF]

				S. Karmakar, R. Dhar, and C. Das Inhibition of Cytotrophoblastic (JEG-3) Cell Invasion by Interleukin 12 Involves an Interferon {gamma}-mediated Pathway J. Biol. Chem., December 31, 2004; 279(53): 55297 - 55307. [Abstract] [Full Text] [PDF]

				D. D. Mruk and C. Y. Cheng Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis Endocr. Rev., October 1, 2004; 25(5): 747 - 806. [Abstract] [Full Text] [PDF]

				A. Iwase, R. Shen, D. Navarro, and D. M. Nanus Direct Binding of Neutral Endopeptidase 24.11 to Ezrin/Radixin/Moesin (ERM) Proteins Competes with the Interaction of CD44 with ERM Proteins J. Biol. Chem., March 19, 2004; 279(12): 11898 - 11905. [Abstract] [Full Text] [PDF]

				J Alami, B R Williams, and H Yeger Differential expression of E-cadherin and {beta} catenin in primary and metastatic Wilms's tumours Mol. Pathol., August 1, 2003; 56(4): 218 - 225. [Abstract] [Full Text] [PDF]

				J. P. Bilello, E. E. Cable, and H. C. Isom Expression of E-Cadherin and Other Paracellular Junction Genes Is Decreased in Iron-Loaded Hepatocytes Am. J. Pathol., April 1, 2003; 162(4): 1323 - 1338. [Abstract] [Full Text] [PDF]

				M. Sanchez-Carbayo, N. D. Socci, E. Charytonowicz, M. Lu, M. Prystowsky, G. Childs, and C. Cordon-Cardo Molecular Profiling of Bladder Cancer Using cDNA Microarrays: Defining Histogenesis and Biological Phenotypes Cancer Res., December 1, 2002; 62(23): 6973 - 6980. [Abstract] [Full Text] [PDF]

				T. Makitie, O. Carpen, A. Vaheri, and T. Kivela Ezrin as a Prognostic Indicator and Its Relationship to Tumor Characteristics in Uveal Malignant Melanoma Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2442 - 2449. [Abstract] [Full Text] [PDF]

				W. Wick, C. Grimmel, C. Wild-Bode, M. Platten, M. Arpin, and M. Weller Ezrin-Dependent Promotion of Glioma Cell Clonogenicity, Motility, and Invasion Mediated by BCL-2 and Transforming Growth Factor-{beta}2 J. Neurosci., May 15, 2001; 21(10): 3360 - 3368. [Abstract] [Full Text] [PDF]

				D G. R Evans, M Sainio, and M. E Baser Neurofibromatosis type 2 J. Med. Genet., December 1, 2000; 37(12): 897 - 904. [Abstract] [Full Text]

				N. R. Filipenko and D. M. Waisman The C Terminus of Annexin II Mediates Binding to F-actin J. Biol. Chem., February 9, 2001; 276(7): 5310 - 5315. [Abstract] [Full Text] [PDF]